关注
Hartmut Döhner
Hartmut Döhner
Professor of Medicine
在 uniklinik-ulm.de 的电子邮件经过验证
标题
引用次数
引用次数
年份
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
H Döhner, E Estey, D Grimwade, S Amadori, FR Appelbaum, T Büchner, ...
Blood, The Journal of the American Society of Hematology 129 (4), 424-447, 2017
58262017
Genomic aberrations and survival in chronic lymphocytic leukemia
H Döhner, S Stilgenbauer, A Benner, E Leupolt, A Kröber, L Bullinger, ...
New England Journal of Medicine 343 (26), 1910-1916, 2000
43532000
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
H Döhner, EH Estey, S Amadori, FR Appelbaum, T Büchner, AK Burnett, ...
Blood, The Journal of the American Society of Hematology 115 (3), 453-474, 2010
43172010
Genomic classification and prognosis in acute myeloid leukemia
E Papaemmanuil, M Gerstung, L Bullinger, VI Gaidzik, P Paschka, ...
New England Journal of Medicine 374 (23), 2209-2221, 2016
39932016
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National …
M Hallek, BD Cheson, D Catovsky, F Caligaris-Cappio, G Dighiero, ...
Blood, The Journal of the American Society of Hematology 111 (12), 5446-5456, 2008
39382008
Acute myeloid leukemia
H Döhner, DJ Weisdorf, CD Bloomfield
New England Journal of Medicine 373 (12), 1136-1152, 2015
35452015
Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic …
BD Cheson, JM Bennett, KJ Kopecky, T Büchner, CL Willman, EH Estey, ...
Journal of clinical oncology 21 (24), 4642-4649, 2003
30362003
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
M Hallek, K Fischer, G Fingerle-Rowson, AM Fink, R Busch, J Mayer, ...
The Lancet 376 (9747), 1164-1174, 2010
23972010
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
RM Stone, SJ Mandrekar, BL Sanford, K Laumann, S Geyer, ...
New England Journal of Medicine 377 (5), 454-464, 2017
21742017
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia
RF Schlenk, K Döhner, J Krauter, S Fröhling, A Corbacioglu, L Bullinger, ...
New England Journal of Medicine 358 (18), 1909-1918, 2008
20842008
Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions
V Goede, K Fischer, R Busch, A Engelke, B Eichhorst, CM Wendtner, ...
New England Journal of Medicine 370 (12), 1101-1110, 2014
19212014
Azacitidine and venetoclax in previously untreated acute myeloid leukemia
CD DiNardo, BA Jonas, V Pullarkat, MJ Thirman, JS Garcia, AH Wei, ...
New England Journal of Medicine 383 (7), 617-629, 2020
18662020
Acute myeloid leukaemia
E Estey, H Döhner
The Lancet 368 (9550), 1894-1907, 2006
18012006
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia
F Lo-Coco, G Avvisati, M Vignetti, C Thiede, SM Orlando, S Iacobelli, ...
New England Journal of Medicine 369 (2), 111-121, 2013
1673*2013
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
M Hallek, BD Cheson, D Catovsky, F Caligaris-Cappio, G Dighiero, ...
Blood, The Journal of the American Society of Hematology 131 (25), 2745-2760, 2018
16382018
Matrix‐based comparative genomic hybridization: biochips to screen for genomic imbalances
S Solinas‐Toldo, S Lampel, S Stilgenbauer, J Nickolenko, A Benner, ...
Genes, chromosomes and cancer 20 (4), 399-407, 1997
14311997
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with> 30% blasts
H Dombret, JF Seymour, A Butrym, A Wierzbowska, D Selleslag, JH Jang, ...
Blood, The Journal of the American Society of Hematology 126 (3), 291-299, 2015
13182015
Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia
L Bullinger, K Döhner, E Bair, S Fröhling, RF Schlenk, R Tibshirani, ...
New England Journal of Medicine 350 (16), 1605-1616, 2004
12462004
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
DA Arber, A Orazi, RP Hasserjian, MJ Borowitz, KR Calvo, HM Kvasnicka, ...
Blood, The Journal of the American Society of Hematology 140 (11), 1200-1228, 2022
12242022
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
H Döhner, AH Wei, FR Appelbaum, C Craddock, CD DiNardo, H Dombret, ...
Blood, The Journal of the American Society of Hematology 140 (12), 1345-1377, 2022
12032022
系统目前无法执行此操作,请稍后再试。
文章 1–20